Bibliografia

• Ameye LG, Chee WS. Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther 2006; 8(4): R127.
• Anon A. La glucosamina merita di essere impiegata nell’osteoartrosi? DTB 2002; 11: 81-3.
• Bello AE, Oesser S. Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature. Curr Med Res Opin 2006; 22(11): 2221-32.
• Beer C, Wood S, Veghte RH. A randomized, double-blind, placebo-controlled clinical trial to investigate the effect of Cynatine® FLX on Symptoms of osteoarthritis. J Diet Suppl 2013; 10(3): 184-94.
• Black C, Clar C, Henderson R, et al. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Health Technol Assess 2009; 13(52): 1-148.
• Block JA, Oegema TR, Sandy JD, Plaas A. The effects of oral glucosamine on joint health: is a change in research approach needed? Osteoarthritis Cartilage 2010; 18(1): 5-11.
• Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulphate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006; 354: 795-807.
• De Silva V, El-Metwally A, Ernst E, Lewith G, Macfarlane GJ. Arthritis Research UK Working Group on Complementary and Alternative Medicines. Evidence for the efficacy of complementary and alternative medicines in the management of osteoarthritis: a systematic review. Rheumatology (Oxford) 2011; 50(5): 911-20.
• Deal CL, Moskowitz RW. Nutraceuticals as therapeutic agents in osteoarthritis.The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am 1999; 25(2): 379-95.
• Goldberg VM, Buckwalter JA. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage 2005; 13(3): 216-24.
• Henrotin Y, Lambert C, Couchourel D, Ripoll C, Chiotelli E. Nutraceuticals: do they represent a new era in the management of osteoarthritis? A narrative review from the lessons taken with five products. Osteoarthritis Cartilage 2011; 19(1): 1-21.
• Henrotin Y, Mobasheri A, Marty M. Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? Arthritis Res Ther 2012 30; 14(1): 201.
• Jobanputra P. Structural and symptomatic efficacy of glucosamine and chondroitin: relevant financial interest? Arch Intern Med 2004; 164: 338-39.
• Kujala UM, Jaakkola LH, Koskinen SK, et al. Scoring of patellofemoral disorders. Arthroscopy 1993; 9: 159-63.
• Leong DJ, Choudhury M, Hirsh DM, et al. Nutraceuticals: potential for chondroprotection and molecular targeting of osteoarthritis. Int J Mol Sci 2013; 14(11): 23063-85.
• Poolsup N, Suthisisang C, Channark P, Kittikulsuth W. Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials. Ann Pharmacother 2005; 39: 1080-87.
• Richy F, Bruyere O, Ethgen O, et al. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis. A comprehensive meta-analysis. Arch Intern Med 2003; 163: 1514-22.
• Rodriguez-Merchan EC. Evidence based conservative management of patello-femoral syndrome. Arch Bone Jt Surg 2014; 2(1): 4-6.
• Rubino S, Acciarini AE. Il trattamento dell’osteoartrosi. IsF 2001; 4: 98-103.
• Schauss AG, Stenehjem J, Park J, et al. Effect of the novel low molecular weight hydrolyzed chicken sternal cartilage extract, BioCell Collagen, on improving osteoarthritis-related symptoms: a randomized, double-blind, placebo-controlled trial. J Agric Food Chem 2012; 60: 4096-101.
• Towheed TE, Maxwell L, Anastassiades TP, et al. Glucosamine therapy for treating osteoarthritis. The Cochrane Database of Systematic Reviews 2005, Issue 2.
• Vallières M, du Souich P. Modulation of inflammation by chondroitin sulfate. Osteoarthritis Cartilage 2010;18 Suppl 1: S1-6.